📊 etf · US

XLV

etf · US
etf US
Overall assessment · Trend now + news, 30 days ?
▼ Strongly bearish strong Confidence 45 % ?
News situation · 1 items / 30 D
▼ Bearish strong 45 %
7.0 Impact / 10
News, 30 days
Bearish
Chart

XLV chart by timeframe

Trendlines, support and resistance and patterns come from the newest signal of the selected timeframe.

XLV · 15M
Loading chart

No signal on this timeframe — price and EMA only.

Signal history

Both worlds over time

Technical and news signals of the last 90 days on one timeline.

Bullish ▲Bearish ▼18.05. · News signal · Impact 2/1015.06. · News signal · Impact 3/1022.07. · News signal · Impact 7/10
90 days ago today
Technical signal News signal Size = strength
News, 30 days

What is being reported about XLV

Asset Snapshot

📝 Overview Generated automatically?

XLV has been the subject of 3 signals across 3 articles in the last 365 days. Sentiment skews Bearish (67%).

Breakdown: 1 bullish, 2 bearish, 0 neutral. AI confidence averages 54% across all signals.

Most-cited catalysts: Supreme Court ruling on Lilly sets potential precedent for Medicaid cases (1×), Positive sentiment from new healthcare IPO (1×), Tariff announcement triggers healthcare sell-off (1×). Most-cited risk factors: Other pharma companies may have stronger defenses (1×), Market may not view this as a sector-wide issue (1×), Minimal direct impact on large ETF; IPO may be small (1×).

Keep exploring

Related assets

Same category or comparable signal picture — each card opens the full cockpit.